SCHEMBL15929409

SCHEMBL15929409

CCNC12CNCCNCC(NCc3ccc(N4C(=O)C=CC4=O)cc3)(CNCCNC1)CNCCNC2

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 14/20 0.48
FAAH O00519 5/20 0.42
HSP90AA1 P07900 4/20 0.36
TDP1 Q9NUW8 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
PKM P14618 1/20 0.36
MAPK1 P28482 1/20 0.36
ALDH1A1 P00352 3/20 0.35
CACNA1B Q00975 2/20 0.35
APBA1 Q02410 2/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
LMNA P02545 3/20 0.33
CCR6 P51684 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
MAPT P10636 1/20 0.33
RECQL P46063 1/20 0.33
ELANE P08246 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15928046 0.94 MGLL (0.47) MGLLFAAHHSP90AA1TDP1NPSR1
SCHEMBL15929435 0.90 MGLL (0.45) MGLLFAAHHSP90AA1TDP1NPSR1
SCHEMBL15928048 0.88 MGLL (0.42) MGLLFAAHHSP90AA1TDP1NPSR1
SCHEMBL22479280 0.77 MEN1 (0.38) TDP1ALDH1A1HPGDLMNAMAPT
SCHEMBL22236844 0.75 CA12 (0.35) ALDH1A1HPGDHTTLMNAMAPT
SCHEMBL15929419 0.74 MAPT (0.41) TDP1ALDH1A1LMNAMAPT
SCHEMBL18133295 0.74 MGLL (0.39) MGLLFAAHHSP90AA1TDP1NPSR1
SCHEMBL15929407 0.74 LMNA (0.35) ALDH1A1LMNAMAPTRECQL
SCHEMBL15929413 0.71 HDAC6 (0.34) ALDH1A1HPGDHTTLMNARECQL
SCHEMBL15929412 0.71 DNM1 (0.32) ALDH1A1LMNAMAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542267-B2 Cryptate compounds AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) 2023-01-03 US disclosed
US-11535623-B2 Cryptate compounds AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) 2022-12-27 US disclosed
US-20200308183-A1 CRYPTATE COMPOUNDS AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) 2020-10-01 US disclosed
US-20200308182-A1 CRYPTATE COMPOUNDS AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) 2020-10-01 US disclosed
US-10717741-B2 Cryptate compounds AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) 2020-07-21 US disclosed
US-20140219915-A1 CRYPTATE COMPOUNDS AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (AU) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200308183-A1 CRYPTATE COMPOUNDS HCCS, SQOR, NQO1 MGLL 4179/4885FAAH 3726/4885HSP90AA1 3157/4885
US-20140219915-A1 CRYPTATE COMPOUNDS HCCS, SQOR, NQO1 MGLL 4179/4885FAAH 3726/4885HSP90AA1 3157/4885
US-11542267-B2 Cryptate compounds HCCS, SQOR, NQO1 MGLL 4179/4885FAAH 3726/4885HSP90AA1 3157/4885
US-20200308182-A1 CRYPTATE COMPOUNDS HCCS, SQOR, NQO1 MGLL 4179/4885FAAH 3726/4885HSP90AA1 3157/4885
US-10717741-B2 Cryptate compounds HCCS, SQOR, NQO1 MGLL 4179/4885FAAH 3726/4885HSP90AA1 3157/4885
US-11535623-B2 Cryptate compounds HCCS, SQOR, NQO1 MGLL 4179/4885FAAH 3726/4885HSP90AA1 3157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.